TYK Medicines, Inc (HKG:2410)

TYK Medicines Statistics

Total Valuation

TYK Medicines has a market cap or net worth of HKD 10.20 billion. The enterprise value is 9.90 billion.

Market Cap	10.20B
Enterprise Value	9.90B

Important Dates

The last earnings date was Thursday, March 27, 2025.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

TYK Medicines has 370.84 million shares outstanding. The number of shares has increased by 16.91% in one year.

Current Share Class	n/a
Shares Outstanding	370.84M
Shares Change (YoY)	+16.91%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.22%
Owned by Institutions (%)	18.72%
Float	214.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	89,561.28
PB Ratio	20.28
P/TBV Ratio	23.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-24.04
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.97, with a Debt / Equity ratio of 0.37.

Current Ratio	1.97
Quick Ratio	1.59
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-27.34

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-28.86%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-54.86%
Revenue Per Employee	744
Profits Per Employee	-2.69M
Employee Count	153
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	29.30
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.01
Average Volume (20 Days)	2,626,775

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TYK Medicines had revenue of HKD 113,866 and -411.79 million in losses. Loss per share was -1.22.

Revenue	113,866
Gross Profit	14,898
Operating Income	-365.82M
Pretax Income	-412.82M
Net Income	-411.79M
EBITDA	-351.50M
EBIT	-365.82M
Loss Per Share	-1.22

Balance Sheet

The company has 490.01 million in cash and 188.20 million in debt, giving a net cash position of 301.82 million or 0.81 per share.

Cash & Cash Equivalents	490.01M
Total Debt	188.20M
Net Cash	301.82M
Net Cash Per Share	0.81
Equity (Book Value)	502.89M
Book Value Per Share	1.35
Working Capital	297.86M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	13.08%
Operating Margin	-321,276.00%
Pretax Margin	-362,550.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TYK Medicines does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.91%
Shareholder Yield	-16.91%
Earnings Yield	-4.04%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a